Bortezomib and Low Dose Cytarabine in the Treatment of High-risk Myelodysplastic Syndromes
Clinical trial NCT00411905 · COMPLETED
Trial details
- NCT number
- NCT00411905
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-01
- Primary completion
- 2010-07-08
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.